SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356090-22-000006
Filing Date
2022-05-09
Accepted
2022-05-09 16:19:45
Documents
105
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pgen-20220331.htm   iXBRL 10-Q 1552708
2 EX-31.1 pgen-20220331xexx311.htm EX-31.1 10476
3 EX-31.2 pgen-20220331xexx312.htm EX-31.2 10139
4 EX-32.1 pgen-20220331xexx321.htm EX-32.1 5902
5 EX-32.2 pgen-20220331xexx322.htm EX-32.2 5979
  Complete submission text file 0001356090-22-000006.txt   8829097

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pgen-20220331.xsd EX-101.SCH 64221
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pgen-20220331_cal.xml EX-101.CAL 98635
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pgen-20220331_def.xml EX-101.DEF 407934
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pgen-20220331_lab.xml EX-101.LAB 789116
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pgen-20220331_pre.xml EX-101.PRE 597110
99 EXTRACTED XBRL INSTANCE DOCUMENT pgen-20220331_htm.xml XML 1326724
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36042 | Film No.: 22905295
SIC: 2834 Pharmaceutical Preparations